Why is a sarcoidosis reference centre needed in Croatia?

 

A) Forgotten beyond the acute stage: Chronic sarcoidosis and the battle for quality of life

When a patient is diagnosed with sarcoidosis in the acute phase, the healthcare system usually responds quickly and efficiently. Specialists across multiple disciplines coordinate closely to confirm the diagnosis and stabilize the patient. The principal objective is simple: to save life.

However, once the acute phase appears to subside and vital functions are no longer in immediate danger, one of the most difficult and neglected challenges emerges: the healthcare system ceases to view the individual as an active patient.

 

Life after the acute stage – an invisible chronic struggle

Patients who go on to experience chronic sarcoidosis or suffer permanent organ damage face a wide spectrum of problems affecting day-to-day life that healthcare providers regularly overlook. Most subsequent check-ups focus solely on acute disease relapse, while the progressive, functional consequences of the disease – which do not directly threaten life, but deeply erode its quality – remain without systematic attention.

 

Consequences of sarcoidosis impacting daily quality of life

Below is a detailed overview of possible consequences that patients may experience in the chronic phase of the condition and that directly affect everyday life:

1. Chronic fatigue

Relentless exhaustion that does not resolve with rest, accompanied by cognitive impairment (“brain fog”).

Impairs long walks, ordinary household chores, and social engagement.

2. Chronic pain

Joint and muscular pain, neuropathic discomfort, and burning foot or leg pain caused by nerve damage.

Severely restricts mobility, disrupts sleep patterns, and causes emotional distress.

3. Respiratory issues

Pulmonary fibrosis, chronic shortness of breath, air hunger, and persistent dry cough.

Difficulty climbing stairs, walking in humid conditions, and inability to take part in recreation.

4. Neurological consequences

Small fiber neuropathy, peripheral nerve involvement, weakness, stiffness, and vertigo.

Decreased mobility, the need for crutches or other walking aids, and gait instability.

5. Ocular complications

Uveitis, dry eye, blurred vision and sensitivity to light.

Strained reading ability, reduced driving capacity, and hypersensitivity to sunlight and wind.

6. Cardiac complications

Arrhythmias, myocardial inflammation, heart block, and episodes of syncope (brief loss of consciousness).

Requires continuous cardiac surveillance, carries risk during exertion, and poses danger of sudden cardiac death.

7. Endocrine disturbances

Pituitary, adrenal, and thyroid dysfunctions; diabetes insipidus.

Hormone imbalances, systemic dehydration, and extreme fatigue.

8. Cutaneous manifestations

Lupus pernio, persistent hyperpigmentation, lasting changes to the face, and erythematous rashes.

Aesthetic and psychosocial distress, frequently accompanied by social stigma.

9. Gastrointestinal and hepatic involvement

Hepatomegaly, elevated liver enzymes, nausea, and digestive impairment.

Dietary restrictions and reduced absorption of vital nutrients and medications.

10. Increased susceptibility to infection

Consequence of immunosuppressive treatment (corticosteroids, methotrexate, biologics).

Elevated danger from standard pathogens, requiring avoidance of crowds and people who are ill.

11. Psychological impact

Anxiety, depressive disorders, profound isolation, and persistent health uncertainty.

Necessity for ongoing psychological counseling, therapy, and support networks.

12. Loss of work capacity

Due to cumulative fatigue, debilitating pain, cognitive burdens, and physical limitations.

Loss of independence, income and a sense of social usefulness.

13. Thermoregulation and exercise intolerance

For example, a raised body temperature after physical exertion due to reactive inflammation.

The need to limit physical activity and time in the sun.

 

The absence of comprehensive post-acute care

Unfortunately, individuals struggling with chronic symptoms are rarely recognized as requiring specialized ongoing intervention. Instead of actively identifying and managing post-diagnostic chronic syndromes, patients are referred back to general practitioners where their issues are dismissed as “psychosomatic” or “just part of living with sarcoidosis”.

 

The association’s role and the need for awareness

The Sarcoidosis Association highlights this gap in public healthcare and urges every patient to:

recognize their symptoms and refuse to accept them as purely transient or “inevitable”,

insist with primary care providers on targeted specialized diagnostics (such as EMG/NCV, MRI, spirometry, Holter ECG monitoring, hormone profiles, and functional vision and hearing tests),

seek psychological and occupational support to safeguard their functional independence and everyday well-being.

 

Proposed solution: Establishing the Croatian reference centre for sarcoidosis

The association advocates for the creation of a Medical Scientific Committee, dedicated to establishing the Croatian Reference Centre for Sarcoidosis. Such a centre would be tasked with:

developing standard protocols for diagnosing, managing, and monitoring patients,

formulating a list of recommended investigations and examinations for primary and specialist care,

producing clear educational resources for patients and clinicians,

initiating scientific research and publications in cooperation with European sarcoidosis centres,

and ultimately – elevating the quality of life for all individuals living with chronic sarcoidosis.

Conclusion

Sarcoidosis cannot be viewed solely through episodic acute flare-ups and isolated laboratory tests. The true battle begins after immediate danger passes, when the patient must navigate long-term impairments alone.

It is time to recognize that these symptoms are real – the body is seeking stabilization, survival, and dedicated medical support.

For this reason, we will speak, write, and act.

 

B) INITIATIVE TO ESTABLISH THE CROATIAN SARCOIDOSIS REFERENCE CENTRE

The Sarcoidosis Association Croatia, as the national patient organization for sarcoidosis, submits this formal request and proposal to establish the Croatian Reference Centre for Sarcoidosis, which would operate within a clinical hospital centre (KBC Zagreb / Split / Osijek / Rijeka, depending on opportunities for collaboration).

 

Given the complexity of the disease, the increase in chronic forms, the long-term consequences and insufficiently coordinated care, we consider it necessary to provide a reference point for the diagnosis, monitoring and treatment of sarcoidosis in the Republic of Croatia.

 

Aims of this initiative

Founding a designated reference centre operating through a structured multidisciplinary approach.

Harmonizing and standardizing diagnostic and therapeutic guidelines across all medical centres.

Specialist follow-up of chronic forms of the disease and consequences that significantly impair quality of life.

Scientific research and education for healthcare professionals.

Cooperation with European reference networks.




ROADMAP FOR ESTABLISHING THE CENTRE

 

1. Formal institutional commitment

A letter of intent or a decision by the clinical hospital management confirming readiness to establish a reference centre.

Proposal of a responsible person as centre coordinator, a specialist experienced in treating sarcoidosis.



2. Formation of a multidisciplinary expert team

Assembling core specialists representing:

pulmonology,

cardiology,

neurology,

ophthalmology,

dermatology,

rheumatology,

clinical immunology,

physical medicine and rehabilitation,

psychiatry and clinical psychology.



The association proposes appointing a patient representative as an advisory member of the team.



3. Development of a comprehensive strategic proposal

Document setting out:

the legal basis for the centre’s activities,

organizational and administrative hierarchy,

objectives and areas of activity (diagnostics, treatment, follow-up, education and research),

a proposal for the necessary equipment and premises,

a definition of the multidisciplinary approach and follow-up through specialist consultations,

an annual operational and educational blueprint.



4. Ministry of Health submission

Formal submission to the Ministry of Health requesting the status of a reference centre of the Republic of Croatia.

Possible inclusion in the public health service network, in cooperation with the Ministry.



5. Physical facility and operational setup

Dedicated outpatient examination facilities and multidisciplinary conference rooms.

Administrative and coordination offices.

IT support and a database for patient management.



6. Launch of the National Sarcoidosis Registry

Developed in cooperation with the Croatian Institute of Public Health (Hrvatski zavod za javno zdravstvo, HZJZ) and AZOP, in accordance with personal data protection regulations.

Purpose: tracking the number of people affected, disease types, responses to treatment, complications and outcomes.

 

7. Formulation of unified guidelines

Standardization of diagnostic and therapeutic protocols, including pulmonary, neurological and cardiac protocols.

Preparation of a document with recommended investigations for general practitioners and specialists.

Establishment of algorithms for monitoring post-acute and chronic phases.



8. Education and knowledge dissemination

Organization of annual symposia, professional meetings and lectures for doctors and other staff.

Cooperation with medical faculties in teaching.



9. Scientific research

Encouraging clinical research, publication of scientific papers and participation in international projects.

Building links with European networks of reference centres.



10. Active patient involvement and cooperation with the association

Exchange of information and joint planning of educational and support content for patients.

Actively involving patients in research and gathering their experiences.

 

CONCLUSION

By establishing the Croatian Reference Centre for Sarcoidosis:

-a central hub for diagnosis and follow-up is created, 

-chronic complications are identified at early stages, 

-care is standardized and regional disparities are reduced, improving patients’ quality of life and positioning Croatia as an equal partner in the European network of healthcare for rare diseases.